Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2021
- Schlagwort
-
Patients
Autoantibodies
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Weiß, Elisabeth
- DOI
-
10.5282/edoc.28847
- URN
-
urn:nbn:de:bvb:19-288476
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Macrini, Caterina
- Weiß, Elisabeth
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Antibodies to myelin oligodendrocyte glycoprotein (MOG): Analysis of the impact of the glycosylation site of MOG for recognition of human autoantibodies and dissection of effector functions of the anti-MOG monoclonal antibody 8-18C5
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Identification and temporal stability of conformational epitopes of autoantibodies against Myelin Oligodendrocyte Glycoprotein recognized by patients with different inflammatory central nervous system diseases
Identification and temporal stability of conformational epitopes of autoantibodies against myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Antibodies to myelin oligodendrocyte glycoprotein (MOG): Analysis of the impact of the glycosylation site of MOG for recognition of human autoantibodies and dissection of effector functions of the anti-MOG monoclonal antibody 8-18C5
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Identification and temporal stability of conformational epitopes of autoantibodies against Myelin Oligodendrocyte Glycoprotein recognized by patients with different inflammatory central nervous system diseases
Identification and temporal stability of conformational epitopes of autoantibodies against myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Antibodies to myelin oligodendrocyte glycoprotein (MOG): Analysis of the impact of the glycosylation site of MOG for recognition of human autoantibodies and dissection of effector functions of the anti-MOG monoclonal antibody 8-18C5
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Identification and temporal stability of conformational epitopes of autoantibodies against Myelin Oligodendrocyte Glycoprotein recognized by patients with different inflammatory central nervous system diseases
Identification and temporal stability of conformational epitopes of autoantibodies against myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis